@DeprescribeUS A5/2: Would pharma be interested? Maybe if fewer meds mean better adherence-->and better outcomes for disease states. #DeprescribingResearchChat
@DeprescribeUS A3/3: maybe our studies will even change attitudes toward future deprescribing for patients, caregivers, and clinicians alike! #DeprescribingResearchChat
@DeprescribeUS A3: What matters to the patient regarding outcomes should matter to us in #research. Quality of life, geriatric syndromes, life space are just some to consider. #DeprescribingResearchChat
@DeprescribeUS A2: Not so much a # research method but stakeholders especially specialists are needed to participate in deprescribing research. #DeprescribingResearchChat